{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:09Z","timestamp":1792807569930,"version":"4.5.0"},"reference-count":30,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":179,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Thyrotropin receptor antibodies (TRAbs) are central to Graves\u2019 disease management, but their long-term kinetics after total thyroidectomy is poorly defined. We aimed to describe long-term TRAb trajectories and identify predictors of decline using clinically relevant thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TRAb levels were measured serially in 1,516 patients after total thyroidectomy. Primary outcomes were time to TRAb &amp;lt; 10 and &amp;lt;2 IU\/L, corresponding to a pragmatic fetal-risk threshold and assay negativity, respectively. Clinical factors (age, sex, body mass index, smoking, preoperative TRAb, and thyroid weight) were evaluated using Kaplan\u2013Meier analyses and multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TRAb levels declined rapidly, with median values falling below 10 IU\/L within 2 years. Among patients with preoperative TRAb \u2265 10 IU\/L, 84.8% reached &amp;lt;10 IU\/L and 60.1% reached &amp;lt;2 IU\/L within 5 years. In multivariable models, younger age, lower preoperative TRAb, and smaller thyroid weight independently predicted earlier decline, whereas sex, body mass index, and smoking did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large post-operative cohort, younger age emerged as an independent predictor of accelerated TRAb decline after total thyroidectomy. Total thyroidectomy yields sustained TRAb decline and may promote immunological remission, particularly in younger patients, by removing the antigenic source before the establishment of long-lived plasma cells. These findings highlight age as a key determinant of TRAb kinetics and provide timelines for counselling and follow-up. Surgery may be especially valuable when a timely TRAb decline is required, such as in younger patients planning pregnancy or those with orbitopathy or antithyroid drug refractoriness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0284","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:42:59Z","timestamp":1766158979000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":2,"title":["Clinical predictors of TRAb decline after total thyroidectomy in patients with Graves\u2019 disease"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-5036","authenticated-orcid":true,"given":"Takahiro","family":"Sasaki","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kihara","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Fujishima","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-4159","authenticated-orcid":true,"given":"Hiroo","family":"Masuoka","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Higashiyama","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2069-4658","authenticated-orcid":true,"given":"Yasuhiro","family":"Ito","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Onoda","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Miya","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026070714010449800_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/jcm14051734","article-title":"K-means clustering reveals long-term thyrotropin receptor antibody patterns in Graves\u2019 disease: insights from a 10-year study with implications for Graves\u2019 orbitopathy","volume":"14","author":"Park","year":"2025","journal-title":"J Clin Med"},{"key":"2026070714010449800_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1507\/endocrj.50.595","article-title":"Changes in serum TSH receptor antibody (TRAb) values in patients with Graves\u2019 disease after total or subtotal thyroidectomy","volume":"50","author":"Takamura","year":"2003","journal-title":"Endocr J"},{"key":"2026070714010449800_bib3","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1210\/jcem.80.8.7543112","article-title":"Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients\u2019 T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?","volume":"80","author":"Soliman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714010449800_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3803\/EnM.2019.34.1.29","article-title":"Graves\u2019 disease: can it be cured?","volume":"34","author":"Wiersinga","year":"2019","journal-title":"Endocrinol Metab"},{"key":"2026070714010449800_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1999.9.727","article-title":"Fetal and neonatal hyperthyroidism","volume":"9","author":"Zimmerman","year":"1999","journal-title":"Thyroid"},{"key":"2026070714010449800_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-999676","article-title":"Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment","volume":"5","author":"Tamaki","year":"1988","journal-title":"Am J Perinatol"},{"key":"2026070714010449800_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026070714010449800_bib8","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/thy.2020.0756","article-title":"Changes in thyrotropin receptor antibody (TRAb) levels following total thyroidectomy or radioactive iodine therapy in patients with refractory Graves\u2019 disease","volume":"31","author":"Kim","year":"2021","journal-title":"Thyroid"},{"key":"2026070714010449800_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"2026070714010449800_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1507\/endocrj.EJ15-0492","article-title":"Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves\u2019 disease","volume":"63","author":"Yoshioka","year":"2016","journal-title":"Endocr J"},{"key":"2026070714010449800_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease: improvement of diagnostic accuracy over different generations of methods \u2013 a systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2026070714010449800_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-0030-1267171","article-title":"Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays","volume":"42","author":"Z\u00f6phel","year":"2010","journal-title":"Horm Metab Res"},{"key":"2026070714010449800_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/thy.2018.0165","article-title":"Incidence of neonatal hyperthyroidism among newborns of Graves\u2019 disease patients treated with radioiodine therapy","volume":"29","author":"Yoshihara","year":"2019","journal-title":"Thyroid"},{"key":"2026070714010449800_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.EJ24-0434","article-title":"Prediction of fetal Graves\u2019 disease among pregnant women with Graves\u2019 disease who have undergone thyroidectomy or radioactive iodine therapy: a retrospective observational study","volume":"72","author":"Hosoda","year":"2025","journal-title":"Endocr J"},{"key":"2026070714010449800_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s002689900122","article-title":"Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves\u2019 disease after subtotal thyroidectomy","volume":"20","author":"Sugino","year":"1996","journal-title":"World J Surg"},{"key":"2026070714010449800_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/antib8020030","article-title":"The ligands for human IgG and their effector functions","volume":"8","author":"de Taeye","year":"2019","journal-title":"Antibodies"},{"key":"2026070714010449800_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000511538","article-title":"Targeting TSH and IGF-1 receptors to treat thyroid eye disease","volume":"9","author":"Neumann","year":"2020","journal-title":"Eur Thyroid J"},{"key":"2026070714010449800_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","article-title":"Serum thyrotropin receptor antibodies concentrations in patients with Graves\u2019 disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and\/or thyroid response modify during the observation period","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"key":"2026070714010449800_bib19","first-page":"98","article-title":"Factors affecting the course of Graves\u2019 orbitopathy and poor response to glucocorticoid treatment followed by orbital radiotherapy","volume":"9","author":"Jagie\u0142\u0142o-Korzeniowska","year":"2022","journal-title":"OphthaTherapy"},{"key":"2026070714010449800_bib20","doi-asserted-by":"crossref","DOI":"10.2196\/42619","article-title":"Predicting smoking prevalence in Japan using search volumes in internet search engines: infodemiology study","volume":"24","author":"Taira","year":"2022","journal-title":"J Med Internet Res"},{"key":"2026070714010449800_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2026070714010449800_bib22","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714010449800_bib23","first-page":"159","article-title":"Age-related therapeutic response to antithyroid drug treatment in Graves\u2019 disease.","volume":"4","author":"Yamada","year":"1994","journal-title":"Thyroid"},{"key":"2026070714010449800_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ncpendmet0508","article-title":"Therapy insight: management of Graves\u2019 disease during pregnancy","volume":"3","author":"Alexander","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2026070714010449800_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40842-018-0054-7","article-title":"Graves\u2019 hyperthyroidism in pregnancy: a clinical review","volume":"4","author":"Nguyen","year":"2018","journal-title":"Clin Diabetes Endocrinol"},{"key":"2026070714010449800_bib26","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","article-title":"A 2023 international survey of clinical practice patterns in the management of Graves disease: a decade of change","volume":"109","author":"Villagelin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714010449800_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0663","article-title":"Management of Graves\u2019 hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy","volume":"160","author":"Laurberg","year":"2009","journal-title":"Euro J Endocrinol"},{"key":"2026070714010449800_bib28","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","article-title":"Clinical relevance of thyroid-stimulating immunoglobulins in Graves\u2019 ophthalmopathy","volume":"118","author":"Ponto","year":"2011","journal-title":"Ophthalmology"},{"key":"2026070714010449800_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"2026070714010449800_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00423-023-03153-3","article-title":"TSH receptor autoantibody levels post-total thyroidectomy in Graves\u2019 ophthalmopathy: a meta-analysis","volume":"408","author":"Anees","year":"2023","journal-title":"Langenbecks Arch Surg"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/1\/ETJ-25-0284.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/1\/ETJ-25-0284.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0284\/508673\/etj-25-0284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0284\/508673\/etj-25-0284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:01:11Z","timestamp":1783447271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/1\/ETJ250284\/75644\/Clinical-predictors-of-TRAb-decline-after-total"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0284","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"ETJ250284"}}